Keywords: Bayer, Algeta, Alpharadin, Efficacy, Prostate cancer, Xarelto, Anticoagulant, Almirall, Spain, Co-marketing

Bayer and Algeta’s Alpharadin efficacy confirmed; Almirall to market Xarelto in Spain

Article | 13 February 2012

Print This

German drug major Bayer (BAY: DE) and Norwegian partner Algeta (OSE: ALGETA) announced that the survival analysis has been completed ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in